World No Tobacco Day: Expert shares 5 ways smoking actively damages your mental health
World No Tobacco Day 2025: Every year on May 31, World No Tobacco Day is observed to raise awareness about the ill effects of tobacco on health. WHO has announced the theme for this year - 'Unmasking the Appeal: Exposing Industry Tactics on Tobacco and Nicotine Products.' This campaign intends to shed light on the manipulative tactics the tobacco industry uses to make smoking appear attractive.
While it is already well-known how smoking harms physical health, the toxic content of cigarettes doesn't spare mental health either. In the culture of 'chai sutta breaks', smoking is commonly thought to remove mental roadblocks, beckoning those lightbulb moments of creativity. Even beyond that, it's generally considered a stress buster. But in reality, smoking worsens your mental health in more ways than one.
Dr Pavitra Shankar, psychiatrist at Aakash Healthcare, shared with HT Lifestyle how mental health takes a serious hit because of smoking.
She said, 'Mental health starts to improve within weeks of quitting. People feel calmer, sleep better, and feel more in control. Mood improves, and confidence returns.'
Dr Pavitra shared a guide with us, listing out some of the ways you may be damaging your mental health if you are a smoker:
ALSO READ: 'Sitting is the new smoking': Fitness expert suggests 4 exercises you can do if you sit for too long
Note to readers: This article is for informational purposes only and not a substitute for professional medical advice. Always seek the advice of your doctor with any questions about a medical condition.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hans India
42 minutes ago
- Hans India
Consumer Choice Center Advocates for Significant Revisions to WHO Governance and Operations Amidst Approval of Increased Mandatory Membership
India: The World Health Organization (WHO) is facing intense scrutiny following the approval of a 20% increase in mandatory membership dues, amounting to an additional $120 million per year extracted directly from taxpayers Consumer Choice Center joins critics in questioning whether the organization truly deserves this financial boost, citing significant issues with transparency, accountability, and the allocation of funds. In a country like India, where over 60% of health expenditure is out-of-pocket and public health systems remain severely underfunded, questions around the WHO's spending priorities resonate deeply. The World Health Organization (WHO) recently announced an increase in its mandatory membership dues-known as assessed contributions—by 20%. For 2026 and 2027, this will amount to an additional $120 million per year , drawn straight from taxpayers around the globe. The WHO allocates funding through both voluntary contributions, which are earmarked for specific health programs, and assessed contributions. Assessed contributions provide the WHO leadership, including Director-General Tedros Adhanom Ghebreyesus, with greater discretion in how the funds are utilized. These funds are directed into flexible funding streams. This occurs while global healthcare systems experience challenges related to underfunding, growing waitlists, and staff shortages. Funds are being allocated to various initiatives, including upgrades to the WHO's Geneva headquarters. Senior staff benefits include education allowances of $33,000 per child. The total annual cost for the WHO's 301 most senior staff is approximately $130 million, averaging $432,000 per person, inclusive of benefits and allowances. Sharing his thoughts on the potential utilisation of these additional funds, Fred Roeder, Managing Director, Consumer Choice Center said, 'The $120 million being extracted in new dues each year could directly fund healthcare for 15,000 Germans, 40,000 Poles, 82,000 Georgians, 100,000 South Africans and 500,000 Indians . In India, $120 million annually could fund cancer treatment for 40,000 patients under Ayushman Bharat or cover the full immunization of over 2 million children. That same amount could also strengthen tobacco cessation services across the country, which remain vastly under-resourced despite India having over 260 million tobacco users . Even more troubling, this shift toward 'core funding' is part of a deliberate WHO strategy: to move away from specific, donor-driven initiatives and toward general budget increases it can spend at will—on salaries, travel, and yes, real estate. These are not funds being poured into pandemic preparedness or child vaccination programs. They are being funnelled into a top-heavy administrative structure with minimal transparency and questionable accountability.' The WHO's defenders argue that the organization needs more freedom to respond to global health threats. But freedom without scrutiny leads to mission drift and misallocation. The organization already has a poor record of pandemic response and a reputation for political entanglements. Its handling of tobacco control in India reflects this too—offering ideological prescriptions rather than collaborative, evidence-based support that balances public health, trade, and economic development. The last thing it needs is a blank check. The world needs a lean, targeted health response team. Let's refocus the WHO on solving global health crises, prioritizing impact over institutional expansion. National governments should refuse further increases to assessed contributions until the WHO commits to radical transparency reforms, trims senior compensation packages, and rededicates itself to programmatic funding that puts patient care first. We owe that much to the people who are actually sick—and not just those with corner offices in Geneva. India, as a G20 leader and a major player in global health diplomacy, should demand accountability before committing more taxpayer funds. It must condition future WHO funding on results-driven support for local challenges—like modernizing tobacco regulation, enabling farmer transitions, and enforcing traceability to combat the illicit trade that harms both public health and revenue. Consumer Choice Center The Consumer Choice Center is an independent, non-partisan consumer advocacy group championing the benefits of freedom of choice, innovation, and abundance in everyday life. Through research and educational outreach, we advocate for smart policies that promote growth, lifestyle choice, and tech innovation. We empower consumers to raise their voice and fight for their right to choose—whether it's the products they buy, the technologies they use, or the lifestyle they live.
Time of India
an hour ago
- Time of India
We can forget COVID-19, it's not a cause for concern, say health experts, as they explain the reason behind the surge in India
COVID-19 is becoming milder, but occasional surges are expected. Experts say the virus is endemic and constantly evolving. Rising cases are due to waning immunity and seasonal factors. Vulnerable populations should take precautions. The WHO declared the end of COVID-19 as a public health emergency two years ago. Cases are rising in Southeast Asia, including India. Tired of too many ads? Remove Ads Covid Becoming Milder Every Passing Year: Expert Tired of too many ads? Remove Ads Surge in India part of broader trend Tired of too many ads? Remove Ads 'Ups and downs expected because the virus is endemic' COVID-19 is becoming less severe over time, but occasional increases in cases are expected as the virus becomes endemic and continues to change, scientists say. They reassure the public that there is no major cause for alarm. The experts addressed concerns about the rising number of cases in different parts of India . They believe it is due to weakening immunity combined with seasonal factors, such as extreme temperatures that cause people to stay indoors in air-conditioned environments. They emphasised the need for caution, especially for those who are more vulnerable."With every passing year, COVID-19 is causing milder infections. It is (now) just another respiratory illness and less dangerous than flu. We can forget COVID-19 as a special case. It is not a cause of concern," said Dr. Chandrakant Lahariya, a global health Agarwal from Ashoka University added, "All the subvariants are similar, having a lower virulence but high infectivity. While highly susceptible people can still get severe disease, the vast majority don't, especially those who have had prior infections or vaccines."The World Health Organization (WHO) declared the end of COVID-19 as a public health emergency in May 2023. Health experts now describe the disease as seasonal, endemic, or restricted to certain of June 6, there were over 5,300 active cases in India, with nearly 500 new cases reported in the last 24 hours. More than 4,700 people have recovered. Since January, 55 deaths have been reported, mainly among individuals with pre-existing conditions, according to the Union Health advised that "People with pre-existing illnesses and those older than 65 should follow standard precautions, as they would against any other respiratory infection -- not just for COVID-19."Kerala is the most affected state with over 1,600 cases, followed by Gujarat, West Bengal, Delhi, and Maharashtra, according to ministry increase in cases in India is part of a broader trend in Southeast Asia, including Singapore, Malaysia, Thailand, and Hong surveillance by the Council of Scientific and Industrial Research-National Chemical Laboratory (NCL) has detected the presence of the virus in samples from sewage treatment plants in Pune, according to the Times of sequencing of samples from western and southern India has shown links to Omicron subvariants LF.7, XFG, JN.1, and NB.1.8.1. Rajiv Behl, Director General of the Indian Council of Medical Research (ICMR), said earlier this week that the cases are not severe and there is no need to WHO has classified LF.7 and NB.1.8.1 as 'variants under monitoring' (VUM). JN.1 has been circulating in India since November Satyajit Rath explained that the subvariants are likely better at binding to human cells, despite existing antibodies."However, the important issue here is not their infectivity, but their tendency to cause severe disease, or 'virulence'," Rath experts said that ups and downs in infections are expected because the virus is now endemic and constantly stated, "People need not worry themselves until they are informed of a new 'variant of concern'. VUM is not relevant to the public, but only to public health authorities."Lahariya advised the public to get information from reliable sources and avoid sharing unverified messages. Rath suggested monitoring the virulence of new emphasised that "National and state governments in India should keep a watch on cases, monitor the trends in new cases and share data widely. The linkage between infections and clinical outcomes should be explored to understand the clinical features of the variants in circulation."Rath highlighted the need to address systemic issues in public health systems and healthcare questioned, "Are we making next-generation Covid vaccines at all? Are we making them available widely and affordably? Are we even carefully tracking evidence to see how well or poorly the current vaccine-induced immunity functions against emerging strains?"He added, "And if not, we are throwing poor communities onto their own resources even for taking such simple precautions, and that is a systemic problem."(Inputs from PTI)
Hindustan Times
2 hours ago
- Hindustan Times
IBS vs IBD: Gastroenterologist shares the main differences between the two common gut conditions
Gut health is getting spotlighted in wellness conversations today, and for all the right reasons. Because of the growing discourse around it, there are a lot of remedies and superfoods for common, upset gut issues like bloating, acid reflux, or diarrhoea. But what if these gut issues are actually signs of underlying health conditions that require medical intervention, not just your go-to gut superfoods? IBS and IBD typically share very similar symptoms and may even be confused with everyday digestive issues like bloating, which commonly happens after a heavy meal. It's common to brush them off as minor issues, but they can also hint at IBS and IBD. In an interview with HT Lifestyle, Dr Anukalp Prakash, Director of Gastroenterology at CK Birla, Gurugram, shared the key differences between IBS, IBD, and their symptoms, diagnosis and treatments. He explained the basics, addressing the confusing overlap of symptoms, 'The spread of digestive health problems is on the rise, and two conditions frequently mentioned in such a context are IBS (Irritable Bowel Syndrome) and IBD (Inflammatory Bowel Disease). Even though the two share a common set of symptoms and both involve the gastrointestinal (GI) tract, they are quite distinct in causes, implications, and treatment approaches. Understanding the difference is key to effective management and future well-being. Both IBS and IBD benefit from early diagnosis to be treated most effectively and with the best long-term prognosis.' Dr Anukalp Prakash shared a detailed guide with HT Lifestyle, distinguishing the key differences between IBS and IBD, along with treatment pathways: ALSO READ: Tired of chronic constipation? Doctor reveals 3 seeds to add to your diet for a healthier gut Note to readers: This article is for informational purposes only and not a substitute for professional medical advice. Always seek the advice of your doctor with any questions about a medical condition.
